PBRM1 and endocervical adenocarcinoma: Interestingly, PBRM1 mutations in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) and esophageal carcinoma (ESCA) correlated with robust responses to all five signatures, increasing and decreasing, respectively (Fig 4B).